RNA 5-methylcytosine marks mitochondrial double-stranded RNAs for degradation and cytosolic release
Molecular Cell · 2024-08 · 84 (15) · 2935-2948.e7
DOI: 10.1016/j.molcel.2024.06.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2024-08. Verfasst von Sujin Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea. Hauptthemen laut MEDLINE: Cytosol, 5-Methylcytosine, Mitochondria, RNA Stability. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, National Institute of Dental and Craniofacial Research, National Institutes of Health.
Abstract (Originalsprache)
Mitochondria are essential regulators of innate immunity. They generate long mitochondrial double-stranded RNAs (mt-dsRNAs) and release them into the cytosol to trigger an immune response under pathological stress conditions. Yet the regulation of these self-immunogenic RNAs remains largely unknown. Here, we employ CRISPR screening on mitochondrial RNA (mtRNA)-binding proteins and identify NOP2/Sun RNA methyltransferase 4 (NSUN4) as a key regulator of mt-dsRNA expression in human cells. We find that NSUN4 induces 5-methylcytosine (m5C) modification on mtRNAs, especially on the termini of light-strand long noncoding RNAs. These m5C-modified RNAs are recognized by complement C1q-binding protein (C1QBP), which recruits polyribonucleotide nucleotidyltransferase to facilitate RNA turnover. Suppression of NSUN4 or C1QBP results in increased mt-dsRNA expression, while C1QBP deficiency also leads to increased cytosolic mt-dsRNAs and subsequent immune activation. Collectively, our study unveils the mechanism underlying the selective degradation of light-strand mtRNAs and establishes a molecular mark for mtRNA decay and cytosolic release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
- Xaira Therapeutics, Foster City, CA 94404, USA.
- Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; Graduate School of Engineering Biology, KAIST, Daejeon 34141, Republic o…
Förderung
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
- National Institutes of Health
- National Research Foundation of Korea
Zitieren
APA
Kim, S., Tan, S., Ku, J., Widowati, T. A., Ku, D., Lee, K., You, K., & Kim, Y. (2024). RNA 5-methylcytosine marks mitochondrial double-stranded RNAs for degradation and cytosolic release. Molecular Cell, 84(15), 2935-2948.e7. https://doi.org/10.1016/j.molcel.2024.06.023
Vancouver
Kim S, Tan S, Ku J, Widowati TA, Ku D, Lee K, et al. RNA 5-methylcytosine marks mitochondrial double-stranded RNAs for degradation and cytosolic release. Molecular Cell. 2024;84(15):2935-2948.e7. doi:10.1016/j.molcel.2024.06.023
BibTeX
@article{Kim2024,
author = {Kim, Sujin and Tan, Stephanie and Ku, Jayoung and Widowati, Tria Asri and Ku, Doyeong and Lee, Keonyong and You, Kwontae and Kim, Yoosik},
title = {RNA 5-methylcytosine marks mitochondrial double-stranded RNAs for degradation and cytosolic release},
journal = {Molecular Cell},
year = {2024},
volume = {84},
number = {15},
pages = {2935--2948.e7},
doi = {10.1016/j.molcel.2024.06.023}
}
EUVIMED